Favipiravir

Also known as Avigan, it is an antiviral drug that is in clinical trials to determine whether it can be used as a treatment for COVID-19.

Favipiravir was developed in Japan and originally used to treat influenza there. It is not yet known whether favipiravir can be used to treat patients with COVID-19.

Categories:

Treatment

Cross-reference:

Clinical TrialsCOVID-19